If you're like most investors, then you probably repeatedly made the same mistake as you learned the rules of the game.
You likely spotted a great bargain stock, bought shares and waited for something to happen. Shares likely stayed stuck at bargain levels, testing your patience. And you finally gave up waiting and sold shares, only to discover a year or two later that the stock did eventually rebound in a big way.
What's the lesson learned from that experience? That you should simply wait an indefinite period and stick around long enough for the eventual rebound? No. Such a strategy will lead you to tie up all of your investor dollars in a bunch of dud stocks, leaving you with no funds to pursue new ideas.
The better strategy: Create watch lists and track these stocks. Checking in on them frequently (I prefer daily) allows you to finally hop on board when these stocks start to become timely.
Let me cite a few examples. Shares of Maxwell Technologies (Nasdaq: MXWL), a maker of ultra-capacitors, slumped sharply in the spring of 2012 as the company noted a slowdown in sales and a set of potentially fraudulent actions by some key sales members. These kinds of things can take quite a while to fix. For the next 18 months, shares hovered in the $5 to $9 range, well below the low $20s price seen just a few years earlier.
[More from StreetAuthority.com: 13 Compelling Cash Machines That Are Still Growing]
When I discussed Maxwell back in December shares had yet to show signs of life, which meant that it was a good stock to put on your watch list. That gave you the time to do homework, and wait for better trading action. Indeed, shares rose 15% on Feb. 28, to just above $10, meaning the doldrums had ended. That turned out to be a great time to pounce, as shares are now above $15 and likely headed well higher from here in my view.
Other Breakout Candidates
One of the ways to spot such breakout moves is to track the 100-day moving average (MA). Natural gas storage equipment firm Chart Industries (Nasdaq: GTLS) is one such example. When I profiled this company a month ago on our sister site ProfitableTrading.com, shares had been on a steady downward trend, remaining below the 100-day MA. Yet in recent days, shares have started to breakout, piercing that moving average. Still, shares remain far below the 52-week high and appear to have considerable upside. Clearly, other investors are starting to take note as well.
[More from StreetAuthority.com: Does This 'Hated' Stock Have A Big Drop Coming?]
Another timely break-out stock: Derma Sciences (Nasdaq: DSCI), which is developing a promising new treatment for skin wounds. My profile of this company back in March was ill-timed, as the rout in biotech stocks pushed the group lower. But over the past month, this stock is showing signs of a breakout as management has been delivering a set of well-attended meetings with hedge funds. After forming a base in the $9 area, shares are back above $11, though still below the 52-week high of $15 and my $17 target price.